Suppr超能文献

[原发性经皮冠状动脉介入治疗急性心肌梗死患者血浆肾素活性的评估]

[Evaluation of plasma renin activity in acute myocardial infarction patients treated with primary percutaneous coronary interventions].

作者信息

Stryjewski Piotr J, Pietrucha Artur Z, Stopyra Katarzyna, Nessler Bohdan, Kruszelnicka Olga, Gackowski Andrzej, Konduracka Ewa, Sztefko Krystyna, Badacz Leszek, Nessler Jadwiga

机构信息

Oddział Kardiologii i Chorób Wewnetrznych Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie.

出版信息

Przegl Lek. 2011;68(7):354-8.

Abstract

UNLABELLED

The aim of this study was evaluation of plasma renin activity (PRA) in patients with acute ST-segement elevation myocardial infarction (STEMI) treated with primary percutaneous coronary interventions (PCI). We observed 40 patients (30 men, 10 woman) aged 29-69 yrs (mean age 53.9 SD 10.9) with first ST-segment elevation myocardial infarction. Patients were treated with primary percutaneous coronary intervention (PCI) with implantation of bare metal stent in the period up to 6 hours after the onset of chest pain. Plasma renin activity was evaluated on 1st, 3rd and 5th day and 1st and 3rd month after STEMI in all patients. Values of PRA were compared between men and women during a 3-month follow-up. Echocardiography examinations with left ventricular parameter measurements (included ventricular ejection fraction) were performed at 3rd day, 1st and 3rd month after STEMI. In all patients Troponin I level was measured in the first day of STEMI. In addition, the level of NTproBNP and hsCRP in plasma were measured in all patients at 1st day, 1st and 3rd month after STEMI. Changes of PRA levels within 3-months follow-up were evaluated in relation to the age, BMI, serum levels of NTproBNP, hsCRP, lipids and left ventricular function.

RESULTS

Median value of the PRA was 1.4 ng/ml/h at 1st day (N:1.46 +/- 0.23 ng/ml/h); 2.3 ng/ml/h at 3rd day; 3.9 ng/ml/h at 5th day; 2.1 ng/ml/h at 1 month, and 2.7 ng/ml/h at 3 months after STEMI. Peak value of PRA was observed between 5th day and 1st month after STEMI. PRA was significantly higher in men than in women at 1st day after STEMI (1.8 vs. 0.8 ng/ml/h; p = 0.002). There were no differences of PRA between men and women during the rest of the followup (3rd day - 3.3 vs. 2.0 ng/ml/h; 5th day 7.3 vs. 3.5 ng/ml/h; 1st month 4.1 vs. 2.1 ng/ml/h, 3rd month 3.5 vs. 2.2 ng/ml/h. There was no significant correlation between PRA and age, BMI, serum levels of NTproBNP, hsCRP, lipids and left ventricular function.

CONCLUSIONS

  1. Values of PRA change within early period after STEMI. The peak value was achieved between 5th day and 1st month after STEMI treated with primary PCI. 2. Plasma renin activity was significantly higher in men than in women at 1st day of STEMI treated with primary PCI.
摘要

未标注

本研究旨在评估接受直接经皮冠状动脉介入治疗(PCI)的急性ST段抬高型心肌梗死(STEMI)患者的血浆肾素活性(PRA)。我们观察了40例年龄在29 - 69岁(平均年龄53.9岁,标准差10.9)的首次ST段抬高型心肌梗死患者(30例男性,10例女性)。患者在胸痛发作后6小时内接受了植入裸金属支架的直接经皮冠状动脉介入治疗(PCI)。在所有患者的STEMI后第1天、第3天、第5天以及第1个月和第3个月评估血浆肾素活性。在3个月的随访期间比较了男性和女性的PRA值。在STEMI后第3天、第1个月和第3个月进行了超声心动图检查并测量左心室参数(包括心室射血分数)。在STEMI的第一天测量了所有患者的肌钙蛋白I水平。此外,在STEMI后第1天、第1个月和第3个月测量了所有患者血浆中的NTproBNP和hsCRP水平。在3个月的随访期间,评估了PRA水平的变化与年龄、体重指数、NTproBNP、hsCRP、血脂和左心室功能的血清水平之间的关系。

结果

STEMI后第1天PRA的中位数为1.4 ng/ml/h(N:1.46±0.23 ng/ml/h);第3天为2.3 ng/ml/h;第5天为3.9 ng/ml/h;第1个月为2.1 ng/ml/h,第3个月为2.7 ng/ml/h。PRA的峰值出现在STEMI后第5天至第1个月之间。在STEMI后第1天,男性的PRA显著高于女性(1.8 vs. 0.8 ng/ml/h;p = 0.002)。在随访的其余时间(第3天 - 3.3 vs. 2.0 ng/ml/h;第5天7.3 vs. 3.5 ng/ml/h;第1个月4.1 vs. 2.1 ng/ml/h,第3个月3.5 vs. 2.2 ng/ml/h),男性和女性的PRA没有差异。PRA与年龄、体重指数、NTproBNP、hsCRP、血脂和左心室功能之间没有显著相关性。

结论

  1. STEMI后早期PRA值会发生变化。在接受直接PCI治疗的STEMI后第5天至第1个月达到峰值。2. 在接受直接PCI治疗的STEMI患者中,第1天男性的血浆肾素活性显著高于女性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验